ATF4 and neoplasm: In chronic myeloid leukemia, eIF2α is constitutively phosphorylated and enhances invasive ability of tumor cells but also tumor associated stromal fibroblasts by modulating ECM remodeling through cathepsin and MMPs expression via the induction of ATF4 [154].